Revolution Medicines, Inc. is 1.4x more valuable than BioNTech SE by market capitalization ($30.65 B vs $21.79 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | BNTX | RVMD |
|---|---|---|
| Market cap | $21.79 B | $30.65 B |
| US-listed rank | #587 | #454 |
| Revenue (latest FY) | - | $0.00 |
| Net income (latest FY) | - | -$1.13B |
| SEC filings | 548 | 782 |
Revolution Medicines, Inc. is 1.4x more valuable than BioNTech SE by market capitalization ($30.65 B vs $21.79 B).
Full pages: BioNTech SE and Revolution Medicines, Inc., or browse the full rankings.